Figure 3. Effect of GALNT6 expression on breast cancer survival validated by IHC based on the breast cancer tissue microarray. (A–D) Representative images of negative, weak, moderate and strong were shown, respectively. Immunoreactivity was observed in the cytoplasm of cancer cells. (E) Kaplan-Meier analyses for the OS of breast patients with different levels of GALNT6.